Metsera

Metsera EBIT/Assets

Delisted

The Operating Income to Assets Ratio (EBIT/Assets) of Metsera (MTSR) as of Nov 4, 2026 is -49.85 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -25.86 % — a change of 92.75% (lower).

EBIT/Assets

-49.85 %

YoY

92.75%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Metsera is 2024 -49.85 % . Operating Income to Assets Ratio (EBIT/Assets) of Metsera was 2023 -25.86 % . It decreases by 92.75% lower compared to the previous year.

The Metsera EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2022
-4.45 USD
Jan 1, 2023
-25.86 USD
Jan 1, 2024
-49.85 USD
The Metsera EBIT/Assets history
YEAREBIT/AssetsYoY
-49.85 %+92.75%
-25.86 %+480.87%
-4.45 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Metsera Stock analysis

What does Metsera do? Metsera Inc. is a clinical stage biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on Biotechnology. The company develops next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for treating obesity and related conditions. Utilizing its proprietary MINT peptide library, HALO half-life extension platform, and MOMENTUM oral delivery system, Metsera has a pipeline including MET-097i, MET-233i, and MET-224o, targeting various obesity treatments with differentiated approaches. Listed on 31 January 2025, the company employs 82 staff. Metsera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Metsera stock

Operating Income to Assets Ratio (EBIT/Assets) of Metsera is -49.85 % in 2024.

Operating Income to Assets Ratio (EBIT/Assets) of Metsera changed from -25.86 % to -49.85 %, representing a 92.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Metsera since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Metsera with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Metsera

All Key Metrics — Metsera